Synjardy

Active Ingredient(s): Empagliflozin + Metformin Hydrochloride
FDA Approved: * August 26, 2015
Pharm Company: * BOEHRINGER INGELHEIM
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Synjardy Overview

Empagliflozin, sold under the trade name Jardiance among others, is a medication used together with diet and exercise for the treatment of type 2 diabetes.[1] It may be used together with metformin or insulin.[1] It is not useful for type 1 diabetes.[1] It is taken by mouth.[1] Common side effects include urinary tract infections, join pains, and fungal infections of the groin.[1] Serious side effects may include ...

Read more Synjardy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Empagliflozin

Recent Synjardy Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Empagliflozin + Metformin Hydrochloride
  • Tablet: 12.5mg + 1gm, 12.5mg + 500mg, 12.5mg/1000mg, 12.5mg/500mg, 5mg + 1gm, 5mg + 500mg, 5mg/1000mg, 5mg/500mg
  • Tablet, Extended Release: 10mg + 1gm, 12.5mg + 1gm, 25mg + 1gm, 25mg + 2000mg, 5mg + 1gm
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Synjardy: (4 results)

Sorted by National Drug Code
  • 0597-0159 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0168 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0175 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0180 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (27 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA